Pulse Biosciences earnings were -$80.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest PLSE earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$24.7M, up 32.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PLSE reported annual earnings of -$72.8M, with 35.8% growth.
What were Pulse Biosciences's earnings last quarter?
On PLSE's earnings call on Aug 6, 2026, Pulse Biosciences (NASDAQ: PLSE) reported Q2 2026 earnings per share (EPS) of -$0.36, up 28.57% year over year. Total PLSE earnings for the quarter were -$24.66 million. In the same quarter last year, Pulse Biosciences's earnings per share (EPS) was -$0.28.
As of the last Pulse Biosciences earnings report, Pulse Biosciences is currently losing money. Pulse Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$80.06 million, a 17.68% increase year over year.
What was PLSE's earnings growth in the past year?
As of Pulse Biosciences's earnings date in Aug 6, 2026, Pulse Biosciences's earnings has grown year over year. PLSE earnings in the past year totalled -$80.06 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.